BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 8769865)

  • 1. Solubilization of high-affinity, guanine nucleotide-sensitive mu-opioid receptors from rat brain membranes.
    Weems HB; Chalecka-Franaszek E; Côté TE
    J Neurochem; 1996 Mar; 66(3):1042-50. PubMed ID: 8769865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubilization of high-affinity, guanine nucleotide-sensitive mu-opioid receptors from 7315c cell membranes.
    Cote TE; Gosse ME; Weems HB
    J Neurochem; 1993 Sep; 61(3):973-8. PubMed ID: 8395567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY; Yang HH; Li S; Adams JU
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoprecipitation of high-affinity, guanine nucleotide-sensitive, solubilized mu-opioid receptors from rat brain: coimmunoprecipitation of the G proteins G(alpha o), G(alpha i1), and G(alpha i3).
    Chalecka-Franaszek E; Weems HB; Crowder AT; Cox BM; Côté TE
    J Neurochem; 2000 Mar; 74(3):1068-78. PubMed ID: 10693938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of solubilized opioid receptors: reconstitution and uncoupling of guanine nucleotide-sensitive agonist binding.
    Ofri D; Ritter AM; Liu YF; Gioannini TL; Hiller JM; Simon EJ
    J Neurochem; 1992 Feb; 58(2):628-35. PubMed ID: 1309566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple agonist-affinity states of opioid receptors: regulation of binding by guanyl nucleotides in guinea pig cortical, NG108-15, and 7315c cell membranes.
    Werling LL; Puttfarcken PS; Cox BM
    Mol Pharmacol; 1988 Apr; 33(4):423-31. PubMed ID: 2833686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex.
    Schoffelmeer AN; Yao YH; Gioannini TL; Hiller JM; Ofri D; Roques BP; Simon EJ
    J Pharmacol Exp Ther; 1990 Apr; 253(1):419-26. PubMed ID: 2158552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: a useful model for the study of tolerance at mu opioid receptors.
    Puttfarcken PS; Werling LL; Cox BM
    Mol Pharmacol; 1988 May; 33(5):520-7. PubMed ID: 2835651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of opioid receptors in the Mongolian gerbil cerebellum.
    Niwa M; Iwai T; Luay AE; Nozaki M; Tsurumi K
    Life Sci; 1994; 55(16):1277-83. PubMed ID: 7934629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of opioid receptors in cultured neurons.
    Vaysse PJ; Zukin RS; Fields KL; Kessler JA
    J Neurochem; 1990 Aug; 55(2):624-31. PubMed ID: 2164573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation by mu-opioid agonists of guanosine-5'-O-(3-[35S]thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells.
    Traynor JR; Nahorski SR
    Mol Pharmacol; 1995 Apr; 47(4):848-54. PubMed ID: 7723747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Membrane microviscosity modulates mu-opioid receptor conformational transitions and agonist efficacy.
    Emmerson PJ; Clark MJ; Medzihradsky F; Remmers AE
    J Neurochem; 1999 Jul; 73(1):289-300. PubMed ID: 10386982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid binding sites in the guinea pig and rat kidney: radioligand homogenate binding and autoradiography.
    Dissanayake VU; Hughes J; Hunter JC
    Mol Pharmacol; 1991 Jul; 40(1):93-100. PubMed ID: 1649966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of clocinnamox blockade of opioid receptors: evidence from in vitro and ex vivo binding and behavioral assays.
    Zernig G; Burke T; Lewis JW; Woods JH
    J Pharmacol Exp Ther; 1996 Oct; 279(1):23-31. PubMed ID: 8858971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the effects of glucose in vitro and of the glycaemic state in vivo on the binding characteristics of mu, delta and kappa opiate receptors in mouse brain.
    Khawaja XZ; Green IC
    Life Sci; 1992; 50(17):1273-81. PubMed ID: 1314928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of micro-, kappa-, and delta-opioid receptor density and G protein activation in the cortex and thalamus of monkeys.
    Ko MC; Lee H; Harrison C; Clark MJ; Song HF; Naughton NN; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2003 Jul; 306(1):179-86. PubMed ID: 12676881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of opioid receptor binding by cis and trans fatty acids.
    Remmers AE; Nordby GL; Medzihradsky F
    J Neurochem; 1990 Dec; 55(6):1993-2000. PubMed ID: 2172466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of opioid receptors in rat sensory neurons in culture.
    Chen JJ; Dymshitz J; Vasko MR
    Mol Pharmacol; 1997 Apr; 51(4):666-73. PubMed ID: 9106633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clocinnamox dose-dependently antagonizes morphine-analgesia and [3H]DAMGO binding in rats.
    Paronis CA; Woods JH
    Eur J Pharmacol; 1997 Oct; 337(1):27-34. PubMed ID: 9389377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.